← back to search

Kammi Fox-Kay

U-M Rogel Cancer Center ·

Area of research

Molecular Biology · Genetics

Research interest

Research interests include PI3K/AKT/mTOR signaling in cancer, Chronic Lymphocytic Leukemia Research, Renal Transplantation Outcomes and Treatments, and Biochemical and Molecular Research.

h-index

1

citations

75

works

14

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients

Clinical Cancer Research 2012cited by 74position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anitha Nallari · University of Illinois Chicago1 papers (2012–2012)Michael L. Maitland · Amsterdam University Medical Centers1 papers (2012–2012)Kristin Moshier · University of Kansas1 papers (2012–2012)Gini F. Fleming · Sydney Local Health District1 papers (2012–2012)Kimberly Napoli Eaton · U-M Rogel Cancer Center1 papers (2012–2012)Larry House · University of Chicago1 papers (2012–2012)Mark J. Ratain · University of Chicago1 papers (2012–2012)Samir D. Undevia · University of Chicago1 papers (2012–2012)Thomas F. Gajewski · University of Illinois Chicago1 papers (2012–2012)Jacqueline Ramı́rez · South Western Sydney Local Health District1 papers (2012–2012)Christine Hartford · University of Chicago1 papers (2012–2012)Kehua Wu · Everest University1 papers (2012–2012)Masha Kocherginsky · Northwestern University1 papers (2012–2012)Ezra E.W. Cohen · University of Michigan1 papers (2012–2012)Yuanyuan Zha · University of Chicago1 papers (2012–2012)